Table 3 Tumour diagnoses of patients with malignant tumours.
From: Validation of the state version questionnaire on autonomic regulation (state-aR) for cancer patients
Included | Frequency | Percents |
|---|---|---|
B-chronic lymphatic leukaemia (B-CLL) | 1 | 1.8 |
B-cell Lymphoma (NHL) | 2 | 3.5 |
Breast cancer | 16 | 28.1 |
Bronchial carcinoma (NSCLC) | 5 | 8.8 |
Carcinoma unclear primary (CUP) | 1 | 1.8 |
Cervix carcinoma | 1 | 1.8 |
Colon carcinoma | 4 | 7.0 |
Gallbladder carcinoma | 1 | 1.8 |
Hypernephroma | 1 | 1.8 |
Leiomyosarcoma | 1 | 1.8 |
Melanoma | 1 | 1.8 |
Ovarian carcinoma | 2 | 3,5 |
Ovarian sarcoma | 1 | 1.8 |
Pancreatic cancer | 2 | 3.5 |
Pharynx cancer | 1 | 1.8 |
Plasmocytoma | 4 | 7.0 |
Pleuramesothelioma | 3 | 5.3 |
Prostate cancer | 3 | 5.3 |
Rectal carcinoma | 2 | 3.5 |
Thymus gland carcinoma | 1 | 1.8 |
Thyroid carcinoma | 2 | 3.5 |
Tonsillar carcinoma | 1 | 1.8 |
Urethral cancer | 1 | 1.8 |
Total | 57 | 100.0 |